Central CB2 receptors in inflammation-driven neurodegeneration: dysregulation and therapeutic potential

about

Central CB2 receptors in inflammation-driven neurodegeneration: dysregulation and therapeutic potential

Item

http://www.wikidata.org/entity/Q37387247

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on September 2016

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Central CB2 receptors in infla ...... tion and therapeutic potential

@en

Central CB2 receptors in infla ...... ion and therapeutic potential.

@nl

type

Item

label

Central CB2 receptors in infla ...... tion and therapeutic potential

@en

Central CB2 receptors in infla ...... ion and therapeutic potential.

@nl

prefLabel

Central CB2 receptors in infla ...... tion and therapeutic potential

@en

Central CB2 receptors in infla ...... ion and therapeutic potential.

@nl

P1476

Central CB2 receptors in infla ...... tion and therapeutic potential

@en

P2093

Eilís Dowd

http://www.w3.org/2001/XMLSchema#string

Ruth M Concannon

http://www.w3.org/2001/XMLSchema#string

P2860

Cannabinoid CB2 receptors and fatty acid amide hydrolase are selectively overexpressed in neuritic plaque-associated glia in Alzheimer's disease brains

Symptom-relieving and neuroprotective effects of the phytocannabinoid Δ⁹-THCV in animal models of Parkinson's disease

WIN55,212-2, a cannabinoid receptor agonist, protects against nigrostriatal cell loss in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson's disease.

Neural and immune mechanisms in the pathogenesis of Parkinson's disease.

Upregulation of the cannabinoid CB2 receptor in environmental and viral inflammation-driven rat models of Parkinson's disease.

Differential upregulation of the cannabinoid CB₂ receptor in neurotoxic and inflammation-driven rat models of Parkinson's disease.

Potential of the cannabinoid CB(2) receptor as a pharmacological target against inflammation in Parkinson's disease.

Microglia activation states and cannabinoid system: Therapeutic implications.

P304

1409-1410

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.4103/1673-5374.191208

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Eilís Dowd

Ruth M Concannon

P577

2016-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27857737

http://www.w3.org/2001/XMLSchema#string

P932

5090836

http://www.w3.org/2001/XMLSchema#string